Risk prediction score for severe high altitude illness: A cohort study

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Canouï Poitrine, Florence ^a,b   Veerabudun, Kalaivani ^a,b   Larmignat, Philippe ^c   Letournel, Murielle ^c   Bastuji Garin, Sylvie ^a,b   Richalet, Jean Paul ^c,d  

^a FACULTÉ DE MÉDECINE   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c AVICENNE HOSPITAL   (France)

^d modulations ventilatoires et circulatoires   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; ALTITUDE; ALTITUDE DISEASE; AREA UNDER THE CURVE; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DECISION TREE; DISEASE SEVERITY; EXERCISE TEST; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPOXIA EXERCISE TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIGRAINE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NET RECLASSIFICATION INDEX; PHYSICAL ACTIVITY; PREDICTION; PROCESS DEVELOPMENT; RISK ASSESSMENT; SCORING SYSTEM; SEA LEVEL; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; MIDDLE AGED; RISK FACTOR;

ADULT; ALTITUDE SICKNESS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84904914504     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100642     Document Type: Article

References (24)

1. Bartsch P, Swenson ER (2013) Acute high-altitude illnesses. N Engl J Med 369:1666-1667.
2. Richalet JP, Larmignat P, Poitrine E, Letournel M, Canoui-Poitrine F (2012) Physiological risk factors for severe high-altitude illness: a prospective cohort study. Am J Respir Crit Care Med 185:192-198.
3. Bloch KE, Turk AJ, Maggiorini M, Hess T, Merz T, et al. (2009) Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m. High Alt Med Biol 10:25-32.
4. Honigman B, Theis MK, Koziol-McLain J, Roach R, Yip R, et al. (1993) Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med 118:587-592. (Pubitemid 23102692)
5. Mairer K, Wille M, Bucher T, Burtscher M (2009) Prevalence of acute mountain sickness in the Eastern Alps. High Alt Med Biol 10:239-245.
6. Schneider M, Bernasch D, Weymann J, Holle R, Bartsch P (2002) Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate. Med Sci Sports Exerc 34:1886-1891. (Pubitemid 35440406)
7. Hackett PH, Rennie D, Levine HD (1976) The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 2(7996):1149-1155.
8. Headache Classification Subcommittee of the International Headache S (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia : an international journal of headache 24 Suppl 1:9-160.
9. Lhuissier FJ, Brumm M, Ramier D, Richalet JP (2012) Ventilatory and cardiac responses to hypoxia at submaximal exercise are independent of altitude and exercise intensity. J Appl Physiol 112:566-570.
10. Richalet JP, Gimenez-Roqueplo AP, Peyrard S, Venisse A, Marelle L, et al. (2009) A role for succinate dehydrogenase genes in low chemoresponsiveness to hypoxia? Clin Auton Res 19:335-342.
11. Lhuissier FJ, Canoui-Poitrine F, Richalet JP (2012) Ageing and cardiorespiratory response to hypoxia. The Journal of physiology 590(Pt 21):5461-5474.
12. van Patot MC, Leadbetter G 3rd, Keyes LE, Maakestad KM, Olson S, et al. (2008) Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness. High Alt Med Biol 9:289-293.
13. Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 105:310-315. (Pubitemid 34106178)
14. Hippisley-Cox J, Coupland C (2011) Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. BMJ 343:d4656.
15. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, et al. (2007) Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study BMJ 335:136.
16. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, et al. (2001) Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54:774-781. (Pubitemid 32722180)
17. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157-172; discussion 207-12.
18. Hackett PH, Roach RC (2004) High altitude cerebral edema. High Alt Med Biol 5:136-146. (Pubitemid 39069615)
19. Hackett PH, Roach RC, Schoene RB, Harrison GL, Mills WJ Jr (1988) Abnormal control of ventilation in high-altitude pulmonary edema. J Appl Physiol 64:1268-1272. (Pubitemid 18088552)
20. Matsuzawa Y, Fujimoto K, Kobayashi T, Namushi NR, Harada K, et al. (1989) Blunted hypoxic ventilatory drive in subjects susceptible to high-altitude pulmonary edema. J Appl Physiol 66:1152-1157. (Pubitemid 19091343)
21. Mollard P, Woorons X, Letournel M, Lamberto C, Favret F, et al. (2007) Determinant factors of the decrease in aerobic performance in moderate acute hypoxia in women endurance athletes. Respir Physiol Neurobiol 159:178-186. (Pubitemid 47570112)
22. Dehnert C, Grunig E, Mereles D, von Lennep N, Bartsch P (2005) Identification of individuals susceptible to high-altitude pulmonary oedema at low altitude. Eur Respir J 25:545-551. (Pubitemid 40331187)
23. Savourey G, Guinet A, Besnard Y, Garcia N, Hanniquet AM, et al. (1995) Evaluation of the Lake Louise acute mountain sickness scoring system in a hypobaric chamber. Aviat Space Environ Med 66:963-967.
24. Luks AM, McIntosh SE, Grissom CK, Auerbach PS, Rodway GW, et al. (2010) Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness. Wilderness Environ Med 21:146-155.